Compare Stocks

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALY AnalytixInsight	C$0.08	C$0.07	C$0.05 ▼ C$0.31	C$7.29M	1.74	69,479 shs	31,000 shs
DOCS Doximity	$23.59 -1.3%	$27.08	$19.71 ▼ $36.92	$4.40B	1.17	1.75 million shs	2.23 million shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALY AnalytixInsight	0.00%	+25.00%	0.00%	-6.25%	-71.15%
DOCS Doximity	-2.65%	-5.00%	-11.11%	-19.64%	-31.11%

How a $0.25 cent option contract makes my top traders feel (Ad)

If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time! While I kept the finer details of these $0.25 Cent Trades under wraps until recently…

Click now to see for yourself what $0.25 Cent Trades is all about

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALY AnalytixInsight	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DOCS Doximity	3.2873 of 5 stars	3.0	0.0	0.0	0.0	2.5	4.2	1.9

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALY AnalytixInsight	N/A	N/A	N/A	N/A
DOCS Doximity	2.07	Hold	$28.82	22.19% Upside

Current Analyst Ratings

Latest MKS, MCLS, ALY, and DOCS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
4/25/2024	DOCS Doximity	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Underweight ➝ Neutral	$25.00
4/23/2024	DOCS Doximity	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underweight ➝ Underweight	$25.00 ➝ $25.00
4/2/2024	DOCS Doximity	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	In-Line ➝ In-Line	$30.00
3/15/2024	DOCS Doximity	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underweight ➝ Underweight	$22.00 ➝ $25.00
2/26/2024	DOCS Doximity	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Perform
2/26/2024	DOCS Doximity	SVB Leerink Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Market Perform	$32.00
2/9/2024	DOCS Doximity	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Hold ➝ Hold	$28.00 ➝ $29.00
2/9/2024	DOCS Doximity	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$25.00 ➝ $27.00

(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALY AnalytixInsight	C$1.35M	5.40	C$0.01 per share	11.52	C$0.05 per share	1.50
DOCS Doximity	$419.05M	10.50	$0.69 per share	34.22	$4.98 per share	4.74

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALY AnalytixInsight	-C$3.72M	-C$0.04	N/A	∞	N/A	N/A	-57.32%	-43.77%	5/28/2024 (Estimated)
DOCS Doximity	$112.82M	$0.66	35.74	30.63	3.09	29.39%	16.08%	13.76%	5/21/2024 (Estimated)

Latest MKS, MCLS, ALY, and DOCS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
2/8/2024	Q3 2024	DOCS Doximity	$0.19	$0.25	+$0.06	$0.26	$127.46 million	$135.28 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALY AnalytixInsight	N/A	N/A	N/A	N/A	N/A
DOCS Doximity	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALY AnalytixInsight	0.44	3.09	12.85
DOCS Doximity	N/A	8.03	8.03

Ownership

Institutional Ownership

Company	Institutional Ownership
ALY AnalytixInsight	N/A
DOCS Doximity	87.19%

Insider Ownership

Company	Insider Ownership
ALY AnalytixInsight	7.10%
DOCS Doximity	39.40%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ALY AnalytixInsight	N/A	97.22 million	N/A	Not Optionable
DOCS Doximity	977	186.55 million	113.05 million	Not Optionable

MKS, MCLS, ALY, and DOCS Headlines

Source	Headline
	INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Doximity, Inc. (DOCS) Investors tmcnet.com - April 25 at 7:38 PM
	Doximity to Release Fiscal 2024 Fourth Quarter and Full Year Results on May 16, 2024 businesswire.com - April 25 at 4:01 PM
	DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm accesswire.com - April 25 at 1:15 PM
	3 Medical Services Industry Stocks to Buy as Nursing Market Booms zacks.com - April 25 at 12:11 PM
	JPMorgan Chase & Co. Upgrades Doximity (NASDAQ:DOCS) to "Neutral" marketbeat.com - April 25 at 7:11 AM
	DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm accesswire.com - April 24 at 8:00 PM
	DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors Can Join the Class Action Lawsuit markets.businessinsider.com - April 24 at 8:34 AM
	Doximity (NASDAQ:DOCS) Receives Underweight Rating from Morgan Stanley americanbankingnews.com - April 24 at 4:42 AM
	DOCS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Doximity, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! prnewswire.com - April 24 at 4:00 AM
	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm accesswire.com - April 23 at 5:30 PM
	DOCS INVESTOR NEWS: TOP RANKED ROSEN LAW FIRM Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS businesswire.com - April 23 at 1:53 PM
	Doximity (NASDAQ:DOCS) Rating Reiterated by Morgan Stanley marketbeat.com - April 23 at 12:34 PM
	IMPORTANT INVESTOR ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm prnewswire.com - April 23 at 11:00 AM
	INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity markets.businessinsider.com - April 23 at 9:26 AM
	SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm markets.businessinsider.com - April 22 at 6:41 PM
	Doximity, Inc. (DOCS) Investor Notice: Robbins LLP Reminds Stockholders of the Doximity, Inc. Shareholder Class Action tmcnet.com - April 22 at 6:41 PM
	SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Doximity, Inc. - DOCS prnewswire.com - April 22 at 5:10 PM
	DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Doximity bakersfield.com - April 22 at 1:41 PM
	IMPORTANT INVESTOR NOTICE: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm accesswire.com - April 22 at 7:00 AM
	Cerity Partners LLC Buys New Shares in Doximity, Inc. (NASDAQ:DOCS) marketbeat.com - April 22 at 4:58 AM
	SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Doximity, Inc. with Losses to Contact the Firm accesswire.com - April 21 at 7:00 AM
	Mackenzie Financial Corp Acquires 99,599 Shares of Doximity, Inc. (NASDAQ:DOCS) marketbeat.com - April 21 at 5:34 AM
	Doximity, Inc. (NASDAQ:DOCS) Given Consensus Rating of "Hold" by Analysts americanbankingnews.com - April 21 at 2:30 AM
	SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Doximity, Inc. - DOCS prnewswire.com - April 20 at 12:15 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
April 3, 2024 6:20 AM
View Viking Therapeutics Surges Sentiment for Triple Threat GLP-1Pill
High-Yield Texas Instruments Could Hit New Highs Soon
April 24, 2024 11:27 AM
View High-Yield Texas Instruments Could Hit New Highs Soon
GE Aerospace is Ready for Liftoff After Strong Earnings
April 24, 2024 9:07 AM
View GE Aerospace is Ready for Liftoff After Strong Earnings
5 High Short Interest Stocks Getting Squeezed With Upside To Go
April 5, 2024 9:25 AM
View 5 High Short Interest Stocks Getting Squeezed With Upside To Go
Analysts are Bullish on These 4 Oversold Large Cap Stocks
April 1, 2024 11:37 AM
View Analysts are Bullish on These 4 Oversold Large Cap Stocks

All Headlines

Company Descriptions

AnalytixInsight

CVE:ALY

AnalytixInsight Inc. operates as a data analytics and enterprise software solutions provider to worldwide institutions across various industries. It develops and markets cloud-based platforms, providing financial content, stock trading, and research solutions for banks, brokers, and investors in the financial services industry. The company holds a 49% interest in Marketwall SRL, a developer of FinTech solutions for financial institutions. In addition, it offers financial research and content for investors, information providers, finance portals, and media through its online portals and Connect platform; and system integration services for the workforce management industry. AnalytixInsight Inc. was incorporated in 1999 and is headquartered in Toronto, Canada.

Doximity

NASDAQ:DOCS

Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical manufacturers and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial